SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-23-002227
Filing Date
2023-11-20
Accepted
2023-11-20 17:16:25
Documents
88
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K lxrp_10k.htm   iXBRL 10-K 1313526
2 CONSENT lxrp_ex231.htm EX-23.1 2047
3 CONSENT lxrp_ex232.htm EX-23.2 2483
4 CERTIFICATION lxrp_ex311.htm EX-31.1 11499
5 CERTIFICATION lxrp_ex312.htm EX-31.2 12025
6 CERTIFICATION lxrp_ex321.htm EX-32.1 5922
7 CERTIFICATION lxrp_ex322.htm EX-32.2 6020
  Complete submission text file 0001640334-23-002227.txt   6024342

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20230831.xsd EX-101.SCH 63155
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20230831_lab.xml EX-101.LAB 312528
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20230831_cal.xml EX-101.CAL 48498
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20230831_pre.xml EX-101.PRE 270154
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20230831_def.xml EX-101.DEF 126498
82 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10k_htm.xml XML 1028998
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 231423628
SIC: 2834 Pharmaceutical Preparations